troglitazone has been researched along with thromboxane b2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashton, S; Cook, J; Gilkeson, G; Guyton, K; Halushka, P; Reilly, C; Tempel, G; Teti, G; Zingarelli, B | 1 |
1 other study(ies) available for troglitazone and thromboxane b2
Article | Year |
---|---|
Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
Topics: Animals; Cells, Cultured; Chromans; Enzyme Activation; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; I-kappa B Proteins; Inflammation Mediators; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mitogen-Activated Protein Kinases; Nitric Oxide; Phosphorylation; Prostaglandin D2; Rats; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Staphylococcus aureus; Thiazoles; Thiazolidinediones; Thromboxane B2; Transcription Factors; Troglitazone | 2003 |